Overview
Microphthalmia with limb anomalies, also known as ophthalmoacromelic syndrome or Waardenburg anophthalmia syndrome, is an extremely rare congenital disorder characterized by the combination of severe eye malformations and limb defects. The condition is caused by mutations in the SMOC1 gene, which plays an important role in embryonic development of the eyes and limbs. Affected individuals typically present at birth with bilateral anophthalmia (absence of the eyes) or severe microphthalmia (abnormally small eyes), along with various limb anomalies including syndactyly (fusion of fingers or toes), oligodactyly (fewer than normal digits), and synostosis (abnormal fusion of bones). Additional features may include fibular and tibial defects, as well as other skeletal abnormalities. The condition primarily affects the ocular and musculoskeletal systems. Eye involvement ranges from complete absence of the eyeball to severely reduced eye size, resulting in significant visual impairment or blindness. Limb anomalies can vary in severity and may involve both upper and lower extremities. Some patients may also have additional findings such as intellectual disability or craniofacial anomalies, though these are less consistently reported. The disorder is present from birth and is typically recognized in the neonatal period based on the striking combination of eye and limb findings. There is currently no cure for microphthalmia with limb anomalies. Treatment is supportive and multidisciplinary, involving ophthalmologists for management of eye socket development (including conformers or prosthetic eyes for cosmetic purposes), orthopedic specialists for limb anomalies, and rehabilitation services. Surgical interventions may be considered for specific skeletal malformations. Genetic counseling is recommended for affected families. Early intervention programs addressing visual impairment and any developmental delays are important components of care.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
FDA & Trial Timeline
10 eventsDubai Health Authority — NA
Aga Khan University — NA
Poznan University of Medical Sciences — NA
Cappagh National Orthopaedic Hospital — PHASE4
Washington University School of Medicine — NA
Poznan University of Medical Sciences — NA
Medical University of Graz — NA
Mather's Pharm. Co., Ltd. — PHASE4
Université du Québec à Trois-Rivières — PHASE2
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Microphthalmia with limb anomalies.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Microphthalmia with limb anomalies at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Microphthalmia with limb anomalies.
Community
No community posts yet. Be the first to share your experience with Microphthalmia with limb anomalies.
Start the conversation →Latest news about Microphthalmia with limb anomalies
Disease timeline:
New recruiting trial: Precision Rehabilitation: Mechanisms and Efficacy of Vibration in Exercise Training for Degenerative Knee Osteoarthritis
A new clinical trial is recruiting patients for Microphthalmia with limb anomalies
New recruiting trial: The Effect of Balance Training Using a Dynamometric Platform in Patients Undergoing Total Knee Arthroplasty
A new clinical trial is recruiting patients for Microphthalmia with limb anomalies
New recruiting trial: Effect of Anti-inflammatory (ITIS) Diet in Knee Osteoarthritis
A new clinical trial is recruiting patients for Microphthalmia with limb anomalies
New recruiting trial: Use of Leukocyte-Rich PRP or Leukocyte-Free PRP in the Treatment of Hip Osteoarthritis
A new clinical trial is recruiting patients for Microphthalmia with limb anomalies
New recruiting trial: Amniotic Suspension Allograft Injection for Knee Osteoarthritis
A new clinical trial is recruiting patients for Microphthalmia with limb anomalies
New recruiting trial: Non-weight Bearing in Hip Joint With Accompanying Joint Pain Might Not Progress Radiographic OA
A new clinical trial is recruiting patients for Microphthalmia with limb anomalies
New recruiting trial: Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Shoulder
A new clinical trial is recruiting patients for Microphthalmia with limb anomalies
New recruiting trial: Mobilizing Hispanics With Knee Osteoarthritis
A new clinical trial is recruiting patients for Microphthalmia with limb anomalies
New recruiting trial: COntralateral CorticoSTeroid Injection in Total Knee Arthroplasty
A new clinical trial is recruiting patients for Microphthalmia with limb anomalies
New recruiting trial: Acupuncture vs Sham Acupuncture for Hand Osteoarthritis
A new clinical trial is recruiting patients for Microphthalmia with limb anomalies
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Microphthalmia with limb anomalies
What is Microphthalmia with limb anomalies?
Microphthalmia with limb anomalies, also known as ophthalmoacromelic syndrome or Waardenburg anophthalmia syndrome, is an extremely rare congenital disorder characterized by the combination of severe eye malformations and limb defects. The condition is caused by mutations in the SMOC1 gene, which plays an important role in embryonic development of the eyes and limbs. Affected individuals typically present at birth with bilateral anophthalmia (absence of the eyes) or severe microphthalmia (abnormally small eyes), along with various limb anomalies including syndactyly (fusion of fingers or toes)
How is Microphthalmia with limb anomalies inherited?
Microphthalmia with limb anomalies follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Microphthalmia with limb anomalies typically begin?
Typical onset of Microphthalmia with limb anomalies is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Microphthalmia with limb anomalies?
19 specialists and care centers treating Microphthalmia with limb anomalies are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.